Hedge Fund - Kahn Brothers
Glaxosmithkline Plc (GSK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q1 (2024-03-31) | $53,743,386 | 7.96% | 1,253,644 | $41.24 |
| 2 | 2023 - Q4 (2023-12-31) | $46,676,538 | 7.35% | 1,259,482 | $35.90 |
| 3 | 2023 - Q3 (2023-09-30) | $46,483,403 | 7.25% | 1,282,289 | $35.49 |
| 4 | 2023 - Q2 (2023-06-30) | $45,029,371 | 6.6% | 1,263,458 | $35.87 |
| 5 | 2023 - Q1 (2023-03-31) | $45,453,031 | 6.54% | 1,277,476 | $34.99 |
| 6 | 2022 - Q4 (2022-12-31) | $43,113,031 | 5.67% | 1,226,906 | $33.31 |
| 7 | 2022 - Q3 (2022-09-30) | $38,404,000 | 5.98% | 1,304,939 | $36.31 |
| 8 | 2022 - Q2 (2022-06-30) | $62,297,000 | 8.38% | 1,144,928 | $44.16 |
| 9 | 2022 - Q1 (2022-03-31) | $62,145,000 | 7.89% | 1,141,331.2 | $43.45 |
| 10 | 2021 - Q4 (2021-12-31) | $63,440,000 | 8.71% | 1,150,855.2 | $41.61 |
| 11 | 2021 - Q3 (2021-09-30) | $51,711,000 | 7.27% | 1,082,686.4 | $40.18 |
| 12 | 2021 - Q2 (2021-06-30) | $51,650,880,000 | 7.39% | 1,037,687.2 | $38.44 |
| 13 | 2021 - Q1 (2021-03-31) | $45,175,331,000 | 6.99% | 1,012,616 | $36.31 |
| 14 | 2020 - Q4 (2020-12-31) | $47,174,803,000 | 8.22% | 1,025,539.2 | $36.75 |
| 15 | 2020 - Q3 (2020-09-30) | $52,947,774,000 | 10.03% | 1,125,351.2 | $40.08 |
| 16 | 2020 - Q2 (2020-06-30) | $62,201,000 | 10.51% | 1,214,334.4 | $41.04 |
| 17 | 2020 - Q1 (2020-03-31) | $58,487,000 | 10.69% | 1,234,894.4 | $42.67 |
| 18 | 2019 - Q4 (2019-12-31) | $74,603,000 | 9.04% | 1,270,102.4 | $44.50 |
| 19 | 2019 - Q3 (2019-09-30) | $69,167,000 | 8.67% | 1,296,479.2 | $41.15 |
| 20 | 2019 - Q2 (2019-06-30) | $64,232,000 | 8.03% | 1,284,011.2 | $40.14 |
| 21 | 2019 - Q1 (2019-03-31) | $53,347,000 | 8.33% | 1,021,240 | $39.98 |
| 22 | 2018 - Q4 (2018-12-31) | $48,180,000 | 8.68% | 1,008,752 | $39.40 |
| 23 | 2018 - Q3 (2018-09-30) | $49,871,000 | 7.65% | 993,212.8 | $40.64 |
| 24 | 2018 - Q2 (2018-06-30) | $49,847,000 | 7.93% | 989,273.6 | $40.29 |
| 25 | 2018 - Q1 (2018-03-31) | $48,081,000 | 7.65% | 984,513.6 | $37.26 |
| 26 | 2017 - Q4 (2017-12-31) | $40,406,000 | 6.34% | 911,330.4 | $36.96 |
| 27 | 2017 - Q3 (2017-09-30) | $41,458,000 | 6.33% | 816,908 | $40.59 |
| 28 | 2017 - Q2 (2017-06-30) | $45,495,000 | 6.93% | 844,068 | $42.65 |
| 29 | 2017 - Q1 (2017-03-31) | $44,309,000 | 7.62% | 840,796 | $40.58 |
| 30 | 2016 - Q4 (2016-12-31) | $32,090,000 | 5.41% | 666,652 | $39.52 |
| 31 | 2016 - Q1 (2016-03-31) | $0 | 0% | 0 | $39.84 |
| 32 | 2015 - Q4 (2015-12-31) | $0 | 0% | 0 | $40.78 |
| 33 | 2015 - Q3 (2015-09-30) | $2,211,000 | 0.4% | 46,000 | $41.64 |
| 34 | 2015 - Q2 (2015-06-30) | $2,424,000 | 0.4% | 46,560 | $45.04 |
| 35 | 2015 - Q1 (2015-03-31) | $2,686,000 | 0.45% | 46,560 | $45.86 |
| 36 | 2014 - Q4 (2014-12-31) | $2,180,000 | 0.37% | 40,800 | $44.76 |
| 37 | 2014 - Q3 (2014-09-30) | $2,344,000 | 0.38% | 40,800 | $49.04 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
0.8000:1.0000 on 2022-07-22